Genmab (GMAB) has released an update.
Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
Genmab A/S, a prominent player in the medical research field, has announced plans to expand its share capital by up to DKK 6.6 million by 2029, offering new shares both with and without pre-emption rights for existing shareholders. The company is also issuing warrants to employees, excluding executive management, and introducing convertible debt instruments as part of its growth strategy, all aimed at enhancing flexibility in capital management. These steps are designed to support Genmab’s continued innovation and expansion in the biotech sector.
For further insights into GMAB stock, check out TipRanks’ Stock Analysis page.
